HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Purchase Article View Shopping Cart Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Steele, C. Articles by Herold, K. C. Search for Related Content PubMed PubMed Citation Articles by Steele, C. Articles by Herold, K. C. Social Bookmarking                What's this?

Insulin Secretion in Type 1 Diabetes

¹ Department of Medicine, Division of Endocrinology, and the Naomi Berrie Diabetes Center, College of Physicians and Surgeons, Columbia University, New York, New York
² Pacific Northwest Research Institute, Seattle, Washington
³ Diabetes Center, University of California at San Francisco, San Francisco, California
⁴ Department of Medicine, Indiana University, Indianapolis, Indiana
⁵ Transplant and Autoimmunity Branch, National Institutes of Diabetes and Digestive and Kidney Diseases, Bethesda, Maryland
⁶ Department of Pediatrics, University of Utah, Salt Lake City, Utah

Type 1 diabetes, a chronic autoimmune disease, causes destruction of insulin-producing ß-cells over a period of years. Although many markers of the autoimmune process have been described, none can convincingly predict the rate of disease progression. Moreover, there is relatively little information about changes in insulin secretion in individuals with type 1 diabetes over time. Previous studies document C-peptide at a limited number of time points, often after a nonphysiologic stimulus, and under non–steady-state conditions. Such methods do not provide qualitative information and may not reflect physiologic responses. We have studied qualitative and quantitative insulin secretion to a 4-h mixed meal in 41 patients with newly diagnosed type 1 diabetes and followed the course of this response for 24 months in 20 patients. Newly diagnosed diabetic patients had an average total insulin secretion in response to a mixed meal that was 52% of that in nondiabetic control subjects, considerably higher than has been described previously. In diabetic patients there was a decline of ß-cell function at an average rate of 756 ± 132 pmol/month to a final value of 28 ± 8.4% of initial levels after 2 years. There was a significant correlation between the total insulin secretory response and control of glucose, measured by HbA_1c (P = 0.003). Two persistent patterns of insulin response were seen depending on the peak insulin response following the oral meal. Patients with an early insulin response (i.e., within the first 45 min after ingestion) to a mixed meal, which was also seen in 37 of 38 nondiabetic control subjects, had a significantly accelerated loss of insulin secretion, as compared with those in whom the insulin response occurred after this time (P < 0.05), and significantly greater insulin secretory responses at 18 and 24 months (P < 0.02). These results, which are the first qualitative studies of insulin secretion in type 1 diabetes, indicate that the physiologic metabolic response is greater at diagnosis than has previously been appreciated, and that the qualitative insulin secretory response is an important determinant of the rate of metabolic decompensation from autoimmune destruction.

CiteULike    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				L. B Nielsen, K. B Ploug, P. Swift, C. Orskov, I. Jansen-Olesen, F. Chiarelli, J. J Holst, P. Hougaard, S. Porksen, R. Holl, et al. Co-localisation of the Kir6.2/SUR1 channel complex with glucagon-like peptide-1 and glucose-dependent insulinotrophic polypeptide expression in human ileal cells and implications for glycaemic control in new onset type 1 diabetes Eur. J. Endocrinol., June 1, 2007; 156(6): 663 - 671. [Abstract] [Full Text] [PDF]

				N. A. Sherry, E. B. Tsai, and K. C. Herold Natural History of {beta}-Cell Function in Type 1 Diabetes Diabetes, December 1, 2005; 54(suppl_2): S32 - S39. [Abstract] [Full Text] [PDF]

				M. A. Atkinson Thirty Years of Investigating the Autoimmune Basis for Type 1 Diabetes: Why Can't We Prevent or Reverse This Disease? Diabetes, May 1, 2005; 54(5): 1253 - 1263. [Abstract] [Full Text] [PDF]

				T. Watts, I. Berti, A. Sapone, T. Gerarduzzi, T. Not, R. Zielke, and A. Fasano Role of the intestinal tight junction modulator zonulin in the pathogenesis of type I diabetes in BB diabetic-prone rats PNAS, February 22, 2005; 102(8): 2916 - 2921. [Abstract] [Full Text] [PDF]

				G. Bruno, F. Cerutti, F. Merletti, P. Cavallo-Perin, E. Gandolfo, M. Rivetti, C. Runzo, S. Pinach, G. Pagano, and The Piedmont Study Group for Diabetes Epidemiology Residual {beta}-Cell Function and Male/Female Ratio Are Higher in Incident Young Adults Than in Children: The registry of type 1 diabetes of the province of Turin, Italy, 1984-2000 Diabetes Care, February 1, 2005; 28(2): 312 - 317. [Abstract] [Full Text] [PDF]